Back to state act
Back to state act
Description
On 28 September 2022, Biomedical Advanced Research and Development Authority (BARDA) announced providing USD 31 million in funding to DiaSorin Molecular LLC. The stated objective is to help the compan...
Intervention Details
Intervention Type
State aid, unspecified
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
28 Sep 2022
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Sectors
Affected Products
See all
This intervention is not part of any Thread yet.